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Abstract.  Phenotypically altered C2 myoblast cells, 
generated by the stable transfection of human nonmus- 
cle actin genes (Schevzov, G., C.  Lloyd, and P. Gun- 
ning.  1992. J.  Cell Biol.  117:775-786),  exhibit a dif- 
ferential pattern of tropomyosin cellular organization 
and isoform gene expression.  The/~-actin  transfectants 
displaying a threefold increase in the cell surface area, 
showed no significant changes in the pattern of organi- 
zation of the high Mr tropomyosin isoform, Tm 2, or 
the low Mr tropomyosin isoform, Tm 5.  In contrast, 
the 3'- and Bsm-actin gene transfectants,  exhibiting a 
twofold decrease in the cell surface area,  had an al- 
tered organization  of Tm 2 but not Tm 5.  In these ac- 
tin transfectants,  Tm 2  did not preferentially segregate 
into stress fiber-like structures  and the intensity of 
staining was greatly diminished.  Conversely, a well- 
defined stress fiber-like organization  of Tm 5  was ob- 
served.  The pattern of organization  of these tropomyo- 
sin isoforms correlated with their expression such that 
a profound decrease in Tm 2 expression was observed 
both at the transcript  and protein levels, whereas Tm 5 
remained relatively unchanged.  These results suggest 
that relative changes in nonmuscle actin gene expres- 
sion can affect the organization  and expression of 
tropomyosin in an isoform specific manner.  Further- 
more, this apparent direct link observed between actin 
and tropomyosin expression suggests that nonphar- 
macological signals originating  in the cytoskeleton can 
regulate cytoarchitectural gene expression. 
T 
HE ability of eukaryotic cells to adopt a  variety  of 
shapes  and  to  carry  out  coordinated  and  directed 
movements depends on the cytoskeleton. Many of the 
components that constitute the cytoskeleton of nonmuscle 
ceils belong to a multigene family (Buckingham  and Minty, 
1982).  The presence of distinct but yet similar  cytoskeletal 
isoforms arising  from different genes presumably enables a 
cell to carry out diverse cellular processes such as cell motil- 
ity, organelle and chromosome movement,  cytokinesis,  and 
the generation of cell shape. At present, however, the biolog- 
ical  significance  of these multiple  contractile  protein  iso- 
forms is still  not fully understood. 
In an attempt to address the question of isoform function 
we have  stably transfected  human  nonmuscle actin  genes 
into a mouse myogenic cell line (Schevzov et al., 1992). We 
observed that elevated expression of either the/~- or v-actin 
genes resulted in cells which displayed reciprocal changes in 
the overall  surface area of the ceils.  Correlated with these 
changes in cell morphology was a dramatic change in the or- 
ganization  of the actin microfilament  network.  Additionally, 
elevated expression of a mutant form of the/~-actin gene, one 
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that  codes for  a  stable  but  aberrant  actin  protein  (/~m), 
resulted in cells which displayed a phenotype similar to that 
of the 3¢-actin transfectants. 
The studies presented here were designed to elucidate the 
possible mechanisms by which/$- and 3,-actin may elicit the 
observed changes in cell shape and cytoarchitecture.  Earlier 
studies have shown that different cell types have unique/~:~/ 
ratios (Otey et al., 1987) coupled with distinct cytoarchitec- 
tures.  Analysis of our actin  transfectants  had revealed  that 
changes  in the relative expression of/$- and 3,-actin had oc- 
curred such that different/~:'t  mRNA and protein ratios were 
observed (Schevzov et al., 1992). Consequently,  is an altera- 
tion in the composition of/~- and 3,-actin alone sufficient to 
alter cell shape or is a change  in the composition of other 
cytoskeletal components also required? Previous observa- 
tions have demonstrated  that  a  correlation exists  between 
morphological changes  and the expression of tropomyosin, 
a cytoskeletal component that closely associates  with actin 
microfilaments.  For  example,  morphological  alterations 
coupled with changes in the pattern of tropomyosin gene ex- 
pression  is  a  general  feature  of oncogenic transformation 
(Cooper et al., 1985; Hendricks and Weintraub,  1984; Mat- 
sumura et al., 1983). In addition,  in vitro cellular differentia- 
tion  has  also  been  demonstrated  to  result  in  cell  shape 
changes accompanied by changes in the expression of partic- 
ular tropomyosin isoforms (Ben-Ze'ev et al.,  1989). 
Tropomyosins  are rod-shaped dimeric molecules that  lie 
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1979).  At  present  it  is  known  that  in  skeletal  muscle 
tropomyosin mediates the calcium-ion dependent regulatory 
effect of the troponin complex on actomyosin ATPase activ- 
ity, thereby bringing  about contraction of the muscle (Hux- 
ley,  1972).  The biological function  of this protein in non- 
muscle  cells  still  remains  unclear.  The  observation  that 
tropomyosin can stabilize actin filaments suggests that tropo- 
myosin may play a structural  and/or regulatory role in the 
organization  of microfilaments  and may ultimately  regulate 
cell shape (Wegner,  1982; Bernstein  and Bamburg,  1982). 
The work of Liu and Bretscher (1989) strongly suggests that 
this may be the case.  In yeast, disruption of a tropomyosin 
gene results  in reduced growth rate,  heterogeneity  in cell 
size, and most importantly disruption of actin cables. 
In mammals at least five different nonmuscle tropomyosin 
isoforms have  been identified.  The  high  Mr tropomyosin 
isoforms (Matsumura and Yamashiro-Matsumura,  1985) are 
284 amino acids in length,  have apparent  molecular masses 
on SDS-polyaerylamide gels of 40, 36.5, and 35 kD and are 
commonly known as Tm 1, 2, and 3, respectively.  The low 
Mr tropomyosins are 248 amino acids in length, have appar- 
ent molecular masses of 32.4 and 32 kD and are commonly 
known as Tin 4 and 5, respectively (Matsumura et al., 1983). 
Recently two more 248 amino acid tropomyosins, Tm 5a and 
5b, have been found in rat fibroblasts  (Lees-Miller et al., 
1990). These different isoforms are encoded by a multigene 
family and in mammals four tropomyosin genes have been 
characterized.  In nonmusele  cells the/~-Tm  gene encodes 
Tm 1 (MacLeod et al.,  1985; Helfman et al., 1986); o~-Tmf 
gene encodes Tm 2, 3, 5a and 5b (Wieczorek et al.,  1988; 
Goodwin et al.,  1991); and the Tm 4 gene encodes Tm 4 
(MacLeod et al., 1987; Yammawaki-Kataoka and Helfman, 
1987).  The  fourth  gene  termed  hTm,m by  Reinach  and 
MacI.ex~ (1986) also known as the otTms gene by Gunning 
et al. (1990) since the muscle product of  this gene is preferen- 
tially expressed in slow twitch skeletal muscle, codes for Tm 
5, also known as fibroblast TM30,m (Clayton et al.,  1988). 
The Tm.m gene has until  recently only been characterized 
in humans, however, a recent report by Takenaga et al. (1990) 
demonstrates that the equivalent  gene exists in rodents. 
In an attempt to understand the morphological changes 
observed in our actin  transfectant  clones,  we have inves- 
tigated the cellular organization of two different tropomyosin 
isoforms by immunofluorescence.  We also examined the ex- 
pression of nonmuscle tropomyosin isoforms using isoform 
specific  eDNA  probes.  We  have  found  isoform  specific 
changes to tropomyosin organization and gene expression in 
the different actin gene transfectant  clones suggesting that a 
feedback regulatory mechanism exists for cytoskeletal orga- 
nization  and gene expression  of its components. 
Materials and Methods 
Cell Culture and Transfection 
Actin transfectants were generated by the stable transfection of human non- 
muscle aodn genes into mouse C2 myoblasts as previously described in 
Schevzov et ai. (1992).  In brief, ~20 clones from each transfection were 
randomly selected. All these clones were analyzed for expression of the ex- 
ogenous nonmuscle actin genes and only those expressing the exogenous 
gene at a significant level were chosen for further morphological and bio- 
chemical assays. 
Immunofluorescence Staining 
Cells were seeded on collagen-(Caif Skin Collagen, Caibiochem., Alexan- 
dria, NSW, Australia) coated glass slides for 24 h before fixing and permea- 
bilizing in  1%  formaldehyde followed by  -20°C methanol. Nonspecific 
binding on slides was blocked by incubation at 37°C in PBS containing 10% 
FCS. Antibody incubations were carried out at 37°C for 2 h. Slides were 
washed  extensively  in  PBS  between antibody  incubations  and  finally 
mounted with 1,4-Diazabicyclo[2.2.2]octane (Sigma Chem. Co., St. Louis, 
MO). Cells were examined and photographed on a Zeiss epifluorescence 
microscope with a 40x  objective 0.75 NA. Photographs were taken with 
Kodak T-Max 400 ASA film, developed with D-76, and printed on Agfa b/w 
paper. For matched pairs of double-labeled cells, exposure times for pho- 
tography and printing were identical. 
Antibodies 
The Tin 5 mAb used at 1:1,000 dilution was provided by Drs. J. J.-C.  and 
J. L.-C. Lin and characterized in chicken tissues in Lin et al. (1985a)  and 
in human EJ bladder carcinoma cells in Linet ai. (1988).  The TM311 mAb 
used at  1:400  dilution was purchased from Sigma Chem. Co., St Louis, 
MO. The rabbit antibody which specifically recognizes the Bm-actin pro- 
tein (anti-asp) used at 1:50 dilution was provided by Dr. U. Aebi (~itt 
et al., 1987a). The goat anti-mouse Ig's (G +  L) FITC and goat anti-rabbit 
IgG rhodamine were purchased from ~go Inc. (Burlingame, CA). 
One and Two-Dimensional Gel Electrophoresis and 
Western Transfer 
Total cellular protein was isolated from 30% confluent cells grown in 100- 
ram plastic dishes. Samples were adjusted to equal protein concentrations 
by the method of Lowry et al. (1951) and electrophoresed on 12.5% SDS- 
PAGE gels according to Laemmll (1970)  followed by Western blotting ac- 
cording to Towbin et al. (1979).  Antibody binding was visualized by incuba- 
tion with 1:250  dilution of a  mouse Ig 35S-labeled  antibody (Amersham 
Australia, North Ryde, NSW, Australia) followed by exposure to Kodak 
XAR film (Kodak, North Ryde, NSW, Australia) for 1 d or goat anti-mouse 
alkaline phosphatase (Sigma Chem. Co.). The resulting autoradiographs 
were scanned using a Model 300 series computing densitometer (Molecular 
Dynamics, Inc., Sunnyvale, CA). To correct for any loading discrepancies, 
duplicate gels were run concurrently and one stained with Coomassie bril- 
liant blue. The levels of  protein of each tropomyosin isoform were expressed 
as a percentage of  that seen in the control cells which was set to 100%. Two- 
dimensional gel electrophoresis was performed essentially as described 
(Lin et al., 1988) with the first dimension containing pH 4-6 amphollnes 
and the second dimensional slabs containing 12.5 % acrylamide and 0.104% 
bis-acrylamide. 
D  NA Probes 
Human Nonmuscle  Act/n. Probes specific for the human ~- and 3,-actin 
mRNAs and which do not crosshybridize with the mouse mRNAs, pHFflA- 
3'UT-HH and pI-IFvA-3~JT-HX,  have been characterized previously (Ng et 
al., 1985; Erba et ai., 1986).  These DNA fragments were used to measure 
the level of expression of the transfected human gene in all the mouse C2 
clones relative to that in a human myoblast sample. 
Tm 2 and 3. A probe specific for Tm's 2 and 3 (pR~xTm-lA) was generated 
by PCR  DNA amplification by Dr.  R.  Weinberger (Weinberger et ai., 
1992).  The entire exon la and 79bp of 5'UTR from the rat .-Tmf gene was 
amplified using the following  oligonucleotides 5'GTG GAT CCG CTC GC.A 
CTC CGG CTC TGC CAC 3' and 5' GGT AGA CGC AGA CCT GCT TGC 
3'  (Lees-Miller et al.,  1990).  Amplification was  carried out  using rat 
genomic DNA. This probe detects only the 2.0-kb transcript and does not 
hybridize to the Tm 5a and 5b transcripts also produced by the same gene 
(  c~-Tmf). 
Tm 5a and Jb. A probe specific for Tm 5a and 5b (pRaTm-lB) was gener- 
ated by PCR DNA amplification by Dr. R. Weinberger (Weinberger et ai., 
1992).  The entire exon lb and 78bp of 5'UTR from the rat o~-Tmf  was am- 
plified using oligonucleotides 5' GC~ TCC GTA ACT GCA GGA GCC 3' 
and 5' ~  IU_K3  GTG GAT CCC TAA CGG 3' (Lees-Miller et al., 1990). 
Amplification was carried out using rat genomic DNA. This probe detects 
a 2.0-kb transcript. 
Tm J.  The Tm 5  nonmuscle eDNA (pMMTm5)  was isolated from a 
mouse macrophage eDNA library (Clontech Laboratories Inc., Paio Alto, 
CA). The library was screened with a 32p-labeled cDNA fragment contain- 
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the human a-Trr~ eDNA. Hybridization was in 4× SSC (1× SSC is 0.15 M 
NaCl,  0.015 M  sodium citrate),  50  rnM  NaI-I2PO4 (pH 7.0), 5×  Den- 
hardt's solution (Denhardt,  1966) at 65"C for 16 h, followed by three 30 
rain washes in 0.5× SSC, 50 mM NaI-I2PO4 (pH 7.0), 0.1% SDS at 65"C. 
Partial sequence analysis of an isolated positive clone revealed that it is the 
mouse homologue of the human Tm 5 (Fig. 1, A and B). Furthermore, the 
sequence obtained was identical to that of Takenaga et al. (Takenaga et al., 
1990, accession number X53753) which unambiguously demonstrates that 
it is the mouse Tm 5 nonmuscle isoform. The probe used for Northern blot 
analysis was generated by PCR amplification using the 5' primer 5' CCC 
TGC TC.d3 ACC TGA ACG AG 3' and the 3' primer 5' ACC CCG CAG TC.d2 
AAC TGT TT 3' (denoted in Fig. 1). The reaction was performed with 100 
ng of pMMTm5 and  1 t~g of each primer at an annealing temperature of 
55°C.  A  1,200-bp fragment  was amplified corresponding  to the entire 
YUTR of Tin 5 and which showed no identity to other Tm sequences (data 
not shown). This fragment was subcloned into the HinclI site of  pGEM3Zf, 
to give the plasmid pMMTm5-YUT. This probe detects a 2.5-kb transcript 
in nonmuscle tissues. 
DNA Sequence Analysis 
DNA sequencing was carried out by the dideoxy chain termination method 
(Sanger et al., 1977). Double stranded plasmid DNA was denatured to give 
single stranded DNA using 200 mM sodium hydroxide and 2 mM EDTA, 
and  precipitated  from ethanol  plus  sodium acetate  and  resuspended  in 
water. 
Northern Blots 
Total cellular RNA was isolated from 30% confluent cells by the method 
described by Chomczynski and Sacchi (1987). Total RNA was denatured 
and electrophoresed on 1% agarose gels containing 2.2 M formaldehyde and 
transferred to Hybond N+ (Amersham Australia, North Ryde, NSW, Aus- 
tralia) as described in Maniatis et al.  (1982). Probes were labeled by the 
random priming method (Feinberg and Vogelstein, 1983) and hybridized to 
RNA blots at 109 dpm//~g of DNA in a solution containing 4x  SSC, 50 
mM NaH2PO4 (pH 7.0), 5x  Denhardfs solution (Denhardt,  1966), and 
10% (wt/vol) dextran sulfate at 650C for 16 h. After hybridization, the blots 
were washed at 65"C for 2 h in 0.5x SSC, 0.1% SDS. Filters were exposed 
to Kodak XAR film for 1-3 d. To verify that equivalent amounts of RNA 
were transferred, the RNA blots were hybridized to an 18S specific ribo- 
somal RNA oligonucleotide probe under conditions of probe excess and 
washed at 55°C in 4x SSC, 0.1% SDS. Levels of mRNA were qnantitated 
by densitometry as described  (Gunning et al.,  1990). 
Results 
Specificity of Tropomyosin cDNA Probes 
and Antibodies 
Even though the work of Helfman and coworkers (Goodwin 
et al.,  1991; Lees-Miller and Helfman, 1991) suggests that 
only three tropomyosin genes exist in rodents, Takenaga et 
al. (1990) have in fact cloned and characterized the mouse 
equivalent of the  fourth human  tropomyosin gene,  Tram. 
This gene encodes the mouse nonmuscle Tm 5 protein which 
differs to the human Tm 5 (also known as TM30nm) by a sin- 
gle amino acid. In parallel, we also screened a mouse macro- 
phage eDNA library with a eDNA fragment from the human 
o~Tm, eDNA (see Materials and Methods). Partial sequence 
analysis was performed on the YUTR of the clone obtained 
(Fig. 1 A). A comparison between our clone (pMMTm5) and 
that obtained by Takenaga et al. (Takenaga et al.,  1990) un- 
ambiguously demonstrates that it is the mouse nonmuscle 
Tm 5 isoform. This clone which shares high homology to the 
human  Tm 5  nonmusele isoform (Takenaga et al.,  1990) 
differs from human Tm 4 (MacLex~ et al., 1987) and rat Tm 
4 (Yamawaki-Kataoka and Helfman, 1987). The probe used 
for subsequent Northern blot analysis was generated by PCR 
A 
exol]  ~rlI. 
ATAAACTGAA 
AAGGATQCTG 
GTGCACCAAA  GAGGAGCATC 
5'PCR  primer 
GACCAGACCC  TGCTGGACCT 
TAGACTCCCA  TC'*-Ikb'*  CCGACCGGAG 
3 '  PCR  ~rimer 
CCGCAGTGCA  ACTGTI~GA  TACTGAATAT 
CA~  TAAAGAACCA  GTCCC 
TCTGTACACA 
GAACGAGATG 
AAAGAGAACC 
TGATAAGTGA 
Figure L  Partial nucleotide sequence and Northern blot showing 
the specificity of the pMMTmS-YUT clone.  (A) Nucleotide  se- 
quence at the 5 ' and 3' end of the nonmuscle exon VIII. The PCR 
primers used to generate a Tm 5 isoform specific probe are indi- 
cated. The polyadenylation  site is underlined. Approximately 1,000 
bp have not been sequenced yet and are denoted as ***,~lkb***.  (B) 
Northern blot indicating the specificity of the PCR generated Tm 
5-specific probe. Total cellular RNA was isolated from nonmuscle 
mouse tissues and NIH-3T3 cells. 5/~g of RNA was size fractioned 
and hybridized with the Tm 5 probe (pMMTmS-3'UT)  as described 
in Materials and Methods. The Northern blot was subsequently 
probed with 18S ribosomal RNA to correct for loading discrepan- 
cies. (Lane 1) gastrocnemius; (lane 2) brain; (lane 3) kidney; (lane 
4) testes; (lane 5) liver; (lane 6) stomach; and (lane 7) NIH-3T3. 
as described in Materials and Methods and the primers used 
are denoted in Fig.  1 A. Northern blot analysis using adult 
mouse tissues confirms that mouse Tm 5 has the expression 
pattern  characteristic  of a  nonmuscle  tropomyosin  (Fig. 
1 B). 
The specificity of the two tropomyosin antibodies used in 
this study was determined on total cell extract isolated from 
Rat-l, C2 parental cell line, NIH-3T3, and a pUC18 trans- 
fected C2 clone. As illustrated in Fig. 2 A, the TM311 anti- 
body recognizes two bands of size 40 and 36.5 kD corre- 
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tropomyosin mAbs. Total cell extracts were electrophoresed  on a 
12.5% polyacrylamide gel, transferred to nitrocellulose,  and im- 
munoblotted with a Sigma Chem. Co. tropomyosin mAb (TM311) 
(,4) or a Tm 5 mAb (B). Antibody binding was visualized by in- 
cubating the blot with a mouse 35S-labeled IgG. (,4, lane a) pre- 
stained molecular weight standards; (lane b) Rat-I; (lane c) C2 pa- 
rental cell line; (lane d) NIH-3T3; and (lane e) pUC18 transfected 
C2 clone. (B, lane a) prestained  molecular  weight standards  and 
sponding to Tm 1 and Tm 2 and a much weaker band of 35 
kD (Tm 3) in the Rat-1  and NIH-3T3 cell extracts (lanes b 
and d).  In the C2 and pUC18 transfected cells (Fig.  2  A, 
lanes c and e), the major protein recognized by the antibody 
is Tm 2. Two minor bands corresponding to Tm 1 and 3 are 
also detected in these samples if the immunoblot is overde- 
veloped or overloaded. No reaction is seen with Tm 4  and 
Tm 5  (32.4 and 32 kD) despite the expression of all these 
tropomyosin isoforms in  C2  cells (Gunning  et al.,  1990). 
The Tm 5 antibody (CG3) previously characterized by Lin 
et al.  (1988) and found to detect only the "I'm 5  isoform in 
human EJ bladder carcinoma cells is shown to detect only 
one band of 32 kD in a pUC18 transfected cell extract (Fig. 
2 B, lane b). Since Tm 4 and Tm 5 appear to migrate to the 
same position  in  SDS-PAGE  gels,  the  cross-reactivity of 
this antibody to Tm 4 cannot be determined from one-dimen- 
sional gel electrophoresis. To address this issue, two-dimen- 
sional gel analysis was performed to unambiguously demon- 
strate that this antibody does not cross-react with Tm 4. As 
shown in Fig.  3 B the Tm 5 antibody detects only one iso- 
form.  To demonstrate  that  the  different tropomyosin iso- 
forms were effectively separated, the same Western blot was 
reprobed with the Sigma Chem.  Co.  TM311  antibody.  As 
(lane b) pUC18 transfected C2 clone. The migration positions of 
the mouse tropomyosin isoforms are indicated by the numbers  1, 
2, 3, and 5. Note that the Sigma Chem. Co. TM311 antibody pri- 
marily detects Tin 2 in C2 myoblasts and the Tm 5 antibody detects 
only one band. 
Figure 3. Two-dimensional gel 
eleetrophoresis showing spec- 
ificity of the Tm 5 antibody. 
Total  cellular  protein  from 
normal C2 cells was run with 
the first dimensional gel con- 
taining  pH  4-6  ampholines 
and  the  second  dimensional 
slab  gel  containing  12.5% 
acrylamide, 0.104% bisacryl- 
amide.  (,4) Coomassie blue- 
stained gel,  (B) immtmoblot 
with the Tm 5 mAb,  (C) the 
same immunoblot reacted with 
the Sigma Chem.  Co.  tropo- 
myosin  mAb (TM311) followed 
by  goat  anti-mouse  alkaline 
phosphatase,  and  (D) an en- 
largement  of  (7.  Gels  are 
shown with acidic ends to the 
left.  Nonmuscle tropomyosin 
isoforms are indicated by the 
numbers  1-6. As shown,  the 
Tm 5 mAb preferentially de- 
tects Tm 5. 
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localization  of  tropomyosin 
isoforms  in  the  highest  ex- 
pressing  actin  transfectants. 
Actin transfectant clones with 
the highest level of expression 
of the exogenous genes,  Bun, 
B~t,  /~sm, and  ~-actin  genes 
were  immunofluorescently 
stained with the Tm 2 or Tm 
5 antibodies.  (a, c, e, and g) 
Cells  immunofluorescently 
stained  with  the  Tm 2  mAb 
(TM311) followed by rhoda- 
mine-conjugated  goat  anti- 
mouse  IgG.  (b,  d, f,  and  h) 
Cells  immunofluorescently 
stained  with  the  Tm 5  mAb 
followed by rhodamine-conju- 
gated  goat  anti-mouse  IgG. 
Cells were prepared and treated 
as described in Materials and 
Methods.  (a  and  b)  /$..-33; 
(c  and  d)  B~t-ll; (e  and f) 
3,33-B1; and (g and h)/3~,-22. 
Bar, 10 #m. Note that both the 
~sm-22 and  ~'33-B1 showed  a 
diffuse organization  of Tm 2 
but  displayed a  stress  fiber- 
like organization of Tm 5. 
shown in Fig. 3, C and D, overexposure of the TM311 anti- 
body reveals a clear separation of Tm's 1, 2, 3, and 6. There- 
fore, we can conclude that the Tm 5 antibody does not cross- 
react with Tm 4. There is, however, a formal possibility that 
this antibody may cross-react with Tm 5a and 5b. To assess 
the potential contribution ofTm 5a +  5b, we have hybridized 
the ot-Tmf gene exon  la (see Tm 2  +  3)  and exon  lb (see 
Tm 5a +  5b) probes in parallel to identical filters containing 
C2 cell RNA. We observed only trace hybridization of the 
IB probe and estimate that the level of Tm 5a  +  5b mRNA 
is <5 % of that of Tm 2  +  3 (data not shown). Consequently, 
we expect that subsequent cellular organization studies per- 
formed with this antibody will give a pattern of tropomyosin 
organization that corresponds predominantly to Tm 5. 
Cellular Organization  of Tropomyosin Isoforms in the 
Actin Transfectants 
The cellular organization of tropomyosin was investigated in 
the  different  actin  transfectants  using  the  two  distinct 
tropomyosin antibodies described above. Actin transfectant 
clones exhibiting the highest level of expression of the exoge- 
nous actin genes were chosen for the following studies be- 
cause these cells showed the most severe phenotypic changes 
(Schevzov et al.,  1992). The control cells used are C2 myo- 
blasts transfected with a  triple mutant form of the human 
/~-actin gene (~"), previously shown to cause no detectable 
changes in cell morphology or the actin microfilament net- 
work (Schevzov et al.,  1992). Immunofluorescence staining 
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played a stress fiber-like organization of both ~  2 and Tm 
5 (Fig. 4, a and b). The observed organization of tropomyo- 
sin is the same as that seen by Lazarides (1975) and Lin et 
al.  (1988)  in  other  nonmuscle cell  types.  Similarly,  the 
highest expressing/~,~ clone (B~t-ll) also showed a  stress 
fiber-like organization of Tm 2 and Tm 5 (Fig. 4, c and d). 
However, a diffuse organization of Tm 2 was consistently ob- 
served in the highest expressing 7-actin clone ('y33-B1) (Fig. 
4 e) as compared to the control cells (photo a). In contrast, 
the 3,33-B1 cells displayed highly visible stress fiber-like or- 
ganization ofTm 5 (Fig. 4f). This indicates that actin trans- 
fectants  which  display  different morphologies  may  also 
show a differential pattern of tropomyosin organization. 
Elevated expression of the B,= gene has previously been 
found to elicit a  similar phenotype to that of the 3,-actin 
transfectants. This includes reduced surface area and diffuse 
organization of the actin cables (Schevzov et al.,  1992). 
These similarities also extend to the pattern of expression of 
the endogenous actin genes (Lloyd et al.,  1992).  Do cells 
that exhibit similar alterations in their morphologies and ac- 
tin stress fiber organization also show common changes in 
tropomyosin isoform cellular organization and expression7 
The  highest  expressing  B,m clone  (B,m-22) displayed a 
diffuse organization of Tm 2 (Fig. 4 g) similar to that ob- 
served in the "y33-B1 cells (Fig. 4 e).  Conversely, as in the 
case of the high expressing 7-actin transfectants, "y33-B1, a 
stress fiber-like organization of Tm 5 staining was observed 
in many B,m-22 cells. 
Thus, the impact of high level expression of the/3,=-actin 
gene on Tm 2 and Tm 5 organization parallels that seen with 
the introduced ~,-actin gene, but differs from that in the high 
expressing B~ transfectants and the control cells.  Hence, 
elevated expression  of two  distinct actin  genes  (B,m and 
7-actin) which lead to similar changes in morphology and 
actin  cable  organization  are  also  found to  elicit  similar 
changes in the cytoskeletal organization of Tm 2  but not 
Tm5. 
Expression of the B,, and .y-actin Genes 
Leads to Significant Changes in the Intensity of 
Tropomyosin Staining 
The/3m-22 and "f33-B1 cells displayed a  substantial reduc- 
tion in the intensity ofTm 2 but not Tm 5 immunofluorescent 
staining (Fig. 4). To visualize this differential staining inten- 
sity, C2 parental cells were cocultured with either the ~,m" 
22 or the ~y33-B1 cells. The/~,m-22 cells could be discrimi- 
nated  from  the  C2  parental  cells  by  immunofluorescent 
staining  with  the  antibody  specific  for  the  aberrant  /~m- 
actin protein (anti-asp, Leavitt et al., 1987a). Consequently, 
the cells were reacted with both the anti-asp and either the 
Tm 2 or the Tm 5 antibody. The use of two different second- 
ary antibodies, goat anti-rabbit rhodamine to detect the anti- 
asp and anti-mouse FITC to detect the Tm 2 or the Tm 5 al- 
lowed us to make a direct comparison of staining intensity 
on the same microscopic field. As illustrated in Fig. 5, the 
cells which stained for the aberrant /3,m protein, photo a, 
show negligible staining for Tm 2, photo b, as compared to 
the control cells present in the same field. In contrast, Tm 
5  staining  intensity was  equivalent in  the fl~m expressing 
cells and control C2 cells (Fig. 5 compare c and d). 
Figure 5. Elevated expression of the/~,m gene leads to significant 
changes in  the  intensity of the  tropomyosin staining. Indirect 
double-label immunofluorescence  of Bsm-22 cells cocultured with 
normal C2 cells. A total of 2,500 C2 parental cells were seeded 
together with 2,500 Bsm-22 cells on collagen-coated glass slides. 
Cells were prepared and treated as described in Materials and 
Methods. (a and b) Cells in the same microscopic  field were reacted 
with both the anti-asp and the Tm 2 mAb (TM311), followed by 
rhodamine-conjugated goat anti-rabbit IgG and FITC-conjugated 
goat anti-mouse IgG, respectively. Similarly, (c and d) cells were 
reacted with both the anti-asp and the Tm 5 mAb. Photos a and c 
show the anti-asp localization and b and d show the localization of 
Tm 2 and Tm 5, respectively. Bar, 10 #m. Note the decrease in 
staining intensity of the Bin-22 cells with the Tm 2 antibody as 
compared to control cells but no change in staining intensity with 
the Tm 5 antibody. 
A similar observation was made with cocultures of C2 pa- 
rental cells and 3,33-B1 cells. In this case the detection of the 
"y-actin transfectants was based on their morphology and 
cytoarchitecture (data not shown). In light of these results, 
we conclude that differential expression at the protein level 
of Tm 2 and Tm 5 may occur in these actin transfectants. 
Distinct Expression of Tropomyosin Isoforms in the 
Actin Tmnsfectants 
It is conceivable that the decrease in intensity observed with 
the Tm 2 antibody might be due to epitope blocking in the 
/3sm and  "y-actin  cells.  To  eliminate  this  possibility,  the 
steady-state level of Tm 2 protein was determined by SDS- 
PAGE gel electrophoresis followed by immunoblotting (Fig. 
6). Densitometric scans of the immunoblot revealed that in 
the B.m-22 and 733-B1 cells, Tm 2 was decreased by fivefold 
and fourfold, respectively, whereas the B,~-ll  cells showed 
no significant  changes in Tm 2 levels as compared to the con- 
trol  cells  (/3~-33).  We  conclude,  therefore,  that  the  oh- 
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sity of Tm 2 in the/~-22 and "t3rB1 cells corresponds to a 
decrease in the steady-state protein level. 
The changes in protein content parallel changes in the level 
of mRNA accumulation. Since the highest expressing clone 
from each of the actin transfectants has been shown to elicit 
the most severe phenotypic changes,  tropomyosin mRNA 
levels were initially analyzed in these clones. The levels of 
tropomyosin transcript accumulation in  the B~-33,  /~-11, 
"y3rB1, and/3s,-22 cells (expressed as a percentage of that 
found in a pUC18 transfected cell), were determined by the 
statistical analysis of mRNA values obtained from multiple 
Northern blot determinations (Table I).  In the/3~-33 cells 
no change in the level of expression of Tm 2, 3 was observed 
(Table I). An unexpected result was the downregulation in 
Tm 5 transcript levels. It appears that the presence of  an extra 
actin transcript coding for an unstable protein can impact on 
Tm 5 expression at the mRNA level. The highest expressing 
/~, transfectant, B~,-ll, revealed an increase in mRNA lev- 
els for the tropomyosin isoforms studied (Table I). This is in- 
teresting since no changes in the protein levels of Tm 2 oc- 
curred (103  :t:  15; n  =  2). One possible explanation for this 
discrepancy between protein and mRNA levels could simply 
be due to the fact that the antibody only detects Tm 2 protein, 
whereas for the transcript data the probe used detects both 
Tm 2 and Tm 3 transcript. Hence, the increase in transcript 
may be due to the contribution from Tm 3. In contrast, the 
Figure 6. Western blot analysis showing the distinct expression of 
Tm 2 in the highest expressing actin transfectants. Total cell extract 
isolated  from control  cells  and the  actin transfectants with the 
highest level of expression of the exogenous genes, B~t, #m,/3tin, 
and 3,-actin  genes were electrophoresed on a 12.5 % polyacrylamide 
gel. Duplicate gels run concurrently were either Coomassie blue 
stained (A) or immunoblotted with the Sigma Chem. Co. tropomyo- 
sin mAb (TM 311) (B). Antibody binding was visualized by in- 
cubating the blot with the mouse-35S labeled IgG. (A and B, lane 
/) /3~-11; (lane 2)/3~-22;  (lane 3) /3t~-33; (lane 4) 3,33-B1; and 
(lane 5) pUC18 transfected clone. Migration of molecular mass 
standards are indicated by the numbers 43 and 29 kD. Note the de- 
crease in Tm 2 protein in the Bin-22 and 3,33-B1 ceils. 
Table L Multiple Determinations of Tropomyosin Isoform 
Gene Expression in the Highest Expressing 
Actin Transfectants 
Clone  Tm 2,3  Tm 5 
pUC-A  100  100 
3tm-33  112  +  15  *n  =  5  52  +  8  n  =  5 
3wt-ll  151  +  18  n  =  2  128 +  3  n  =  2 
3sm-22  12 +  1  n =  4  154 5:31 n =  4 
"r33-B1  11  +0.6  n =  4  82 +  10n  =  3 
The level of transcript accumulation of the different Tm isoforms was deter- 
mined in the highest expressing actin transfectants from independent RNA iso- 
lations. The mRNA values are expressed as a  percentage of that found in a 
pUC18 transfeeted clone (pUC-A) which was set to 100% and are represented 
as a  mean +  SD. 
* n  denotes the number of RNA isolations. 
~33-B1 and/~,m-22 cells revealed a decrease in transcript ac- 
cumulation of Tm 2,  3 but not Tm 5  (Table I).  For these 
transfectants, the immunofluorescence staining intensity and 
steady-state  protein  levels  coincide  with  the  observed 
changes in Tm 2 and Tm 5 mRNA levels. 
Subsequent analysis of tropomyosin expression was per- 
formed on actin transfectant clones which expressed the ex- 
ogenous  actin  genes  at  different levels.  This  enabled  the 
evaluation of the relationship between tropomyosin and ex- 
ogenous actin gene expression. 
Northern blots were quantitated by densitometry and the 
results are depicted graphically. Linear regression analysis 
was performed on the data points to determine if significant 
linear relationships exist between the levels of expression of 
the transfected actin genes and that of the tropomyosin iso- 
forms.  Elevated expression of the B~ gene resulted in no 
changes in the mRNA levels of Tm 2, 3 (Fig. 7 A), whereas 
a decrease in Tm 5 was observed (Fig. 7 B). These results 
were confirmed by regression analysis which demonstrated 
that no linear relationship was found to exist between the 
level of the human B~ gene expression and Tm 2,  3  (R  = 
0.57, p  >  0.1) mRNA levels. Surprisingly, a linear relation- 
ship was  found to  exist between/3~ gene expression and 
Tm 5 mRNA levels (R =  0.95, p  <  0.01) suggesting that ex- 
pression of the human/~ gene progressively affected Tm 5 
expression. 
The impact of elevated expression of the human wild-type 
B-actin gene on the levels of tropomyosin isoform mRNAs 
is depicted graphically in Fig. 7, C and D. No linear relation- 
ship  was  found to  exist between the levels of human  B,~ 
gene expression and Tm 2, 3 (R =  0.66, p  <  0.1). The low 
expressing  B~  transfectants  showed  a  heterogeneous  re- 
sponse in Tm 2, 3 transcript levels, and a substantial increase 
in Tm 2, 3 transcript levels was found to occur only in the 
highest expressing B,~ transfectant, B,~-ll  (Table I). In the 
case of the low M, tropomyosin isoform (Tm 5) no linear 
relationship was found to exist between the levels of human 
B~ gene expression and Tm 5  (R =  0.67, p  <  0.1). 
Impact of expression of the human -y-actin gene on the lev- 
els of tropomyosin isoform mRNAs is depicted graphically 
in Fig. 8, A and B. A linear relationship was found to exist 
between the levels of human 3,-actin gene expression and Tm 
2, 3 (R =  0.89, p  <  0.025). Consequently, elevated expres- 
sion of the human 3,-actin gene leads to progressive down- 
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Figure 7. Expression of nonmuscle tropomyosin mRNAs in the Btm 
and 3,t-actin transfectants. Total cellular RNA was isolated from 
four Btm and six B,t-actin transfectants, having different levels of 
expression of the exogenous gene. 3 #g of RNA from each clone 
was size fractionated and hybridized with the tropomyosin isoform 
specific probes Tin 2, 3 (pRc~Tm-lA)  and Tm 5 (pMMTm5-3%IT) 
as described in Materials and Methods. The Northern blots were 
subsequently probed for 18S ribosomal RNA and corrected for 
loading discrepancies. The autoradiograms  were quantitated by 
densitometry and the results are presented as graphs. The mRNA 
values for the different tropomyosin isoforms are expressed as a per- 
centage of that seen in a control cell (pUC18 transfected C2 cells) 
which was set to 100%. The values for the human exogenous gene 
are expressed relative to that seen in a human myoblast RNA sam- 
ple. Graphs A and B correspond to/3tm transfeetants and graphs C 
and D correspond to B~t transfectants. Linear regression analysis 
was performed on the data points and the resulting line is shown 
on each graph. 
regulation of a tropomyosin gene that encodes the high Mr 
tropomyosin isoforms,  Tms 2  and 3.  These results are in 
agreement with the observed decrease in the staining inten- 
sity and steady-state protein levels of Tm 2  in the 733-B1 
cells (Fig. 6, lane 4).  In terms of the low Mr tropomyosin 
isoform, no linear relationship occurred for Tm 5 (R =  0.35, 
p > 0.1). Thus, elevated expression of  the 3,-actin gene results 
in Tm 5 levels remaining relatively unchanged. 
The observed morphological and cytoarchitectural simi- 
larities displayed after elevated expression of the 7-actin and 
the 3m gene also extend to the pattern of mRNA expression 
of  different tropomyosin isoforms. The impact of elevated ex- 
pression of the Bsm gene on the levels of tropomyosin iso- 
form mRNAs is illustrated in Fig. 8, C and D. While a de- 
crease in the levels of Tm 2, 3 with increasing expression of 
the Bs= gene were observed, no such changes occurred to 
Tm 5 transcript levels. An increase in human/3sm gene ex- 
pression resulted in the progressive downregulation of the 
tropomyosin gene encoding the high Mr tropomyosin iso- 
forms, Tms 2 and 3 (R =  0.94, p  <  0.01). However, linear 
regression analysis  demonstrates that  increasing Bs= gene 
C  D 
[ 
100~  -  i  'I  ! 
o 
Human [~  sm  actin  mRNA 
200 
J 
0  1  2 
Human 13  sm  actin  mRNA 
Figure 8.  Expression of nonmuscle tropomyosin mRNAs in the 
7- and/~sm-actin transfectants. Total cellular RNA was isolated from 
four 7- and four B~m-actin  transfectants and analyzed as described 
in Fig. 7. Graphs A and B correspond to 7-actin transfectants and 
graphs C and D to 3,m-actin transfectants. Linear regression anal- 
ysis was performed on the data points and the resulting line  is 
shown on each graph. 
expression has no impact on Tm 5 expression (R =  0.61, p 
>  0.1).  Once  again  these  results  correlate  with  the  im- 
munofluorescence staining intensity (Fig. 5) and protein lev- 
els  of Tm 2  (Fig.  6,  lane  2).  In  general,  the  pattern  of 
tropomyosin gene expression observed in the 3,m transfec- 
tants corresponds to that observed in the 7-actin transfec- 
tants. 
In summary, the results presented show that C2 myoblasts 
which display distinct morphologies and cytoarchitectures 
due to changes in the relative expression of nonmuscle actin 
genes,  differentially regulate tropomyosin isoforms at the 
transcript  and  protein  levels.  Most  importantly,  different 
tropomyosin isoforms respond differently, strongly suggest- 
ing functional differences among the tropomyosin isoforms. 
Furthermore, elevated expression of two distinct actin genes 
previously shown to elicit (a) similar changes in morphology 
and actin cable organization (Schevzov et al., 1992), and (b) 
a similar pattern of expression of the endogenous actin genes 
(Lloyd et al., 1992) were also shown to have a similar impact 
on the pattern of expression of the tropomyosin isoforms. 
These observations suggest that a similar mechanism might 
be operating to regulate tropomyosin expression in response 
to morphological and cytoarchitectural changes arising from 
the impact of two different actin genes. 
Discussion 
Evidence for a Dynamic Equilibrium between 
Cytoskeletal Gene Expression and Changes in 
Cell Shape 
The studies presented in this paper strongly suggest that al- 
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jor cytoskeletal component, actin, can ultimately lead to 
changes in the expression of other components that consti- 
tute the cell cytoskeleton. Hence, elevated expression of two 
distinct actin genes 3'- and/3~, previously shown to elicit 
similar changes in cell morphology and actin cable organiza- 
tion (Schevzov et al.,  1992),  were also shown to give rise 
to similar changes in tropomyosin organization and gene ex- 
pression. Thus, at the transcript level, a decrease in the ex- 
pression of  the Tm 2, 3 gene products was observed, whereas 
the mRNA levels of Tm 5 remained relatively unchanged. 
The distinct pattern of tropomyosin gene expression ob- 
served in these actin transfectants was also found to correlate 
with the distinct cellular organization of  these two tropomyo- 
sin isoforms. The 3"- and B,,-actin transfectants were found 
to exhibit a decrease in the intensity of staining and diffuse 
organization of Tm 2 which parallels with the significant de- 
crease in Tm 2 expression at both the protein and transcript 
levels.  The well-defined stress  fiber-like organization and 
similar staining intensity of Tm 5 is in agreement with no 
significant changes found in the expression of this isoform. 
Additionally, elevated expression of the/~,,-gene, known to 
alter morphology and actin cable organization in a manner 
distinct from elevated 3'- and B~m gene expression, was also 
found to result in a different pattern of tropomyosin gene ex- 
pression to that observed in the 3'-  and /~m transfectants. 
Additional evidence to  support  the observed coordinated 
regulation of cell shape and cytoskeletal gene expression is 
provided by the work of Leavitt et al. (1987a,b).  In their ex- 
periment, the stable transfection of the B,=-actin gene into 
human KD fibroblasts lead to cell shape changes coupled 
with a significant decrease in the protein synthesis of Tm 1, 
2 and 3, whereas Tm 4 and 5 were less affected. Together 
these experiments provide evidence to support a dynamic 
equilibrium between changes in actin gene expression and 
tropomyosin organization and gene expression. 
A Feedback Regulatory Mechanism May Control 
Tropomyosin Gene Expression 
The present study together with that described in Schevzov 
et al. (1992) suggests that the observed changes in tropomyo- 
sin organization and gene expression described above may be 
influenced by the actin composition of the microfilaments. 
Previously reported studies have shown that the aberrant 
Bsm protein is impaired in its ability to form filaments. It 
does however form dimers that can assemble into bundle-like 
structures (Milloning et al., 1988). A total of 80% of the ac- 
tin present in the ~s~,  transfectants consists of the #~ protein 
(Schevzov et al.,  1992).  Therefore, the inability of the/3,m 
protein to form proper filaments may render the filaments in- 
capable of interacting with the high Mr tropomyosin iso- 
forms. The failure of Tm 2 to segregate into the preexisting 
stress fibers may result in the downregulation of Tm 2 both 
at the mRNA and protein levels.  The similar observations 
made in the 3'-actin transfectants in terms of the actin and 
tropomyosin organization strengthen this hypothesis. In this 
case, elevated expression of the 3'-actin gene (0.3/~:3" mRNA 
and protein ratio, Schevzov et al.,  1992) most likely leads 
to actin filaments consisting predominantly of  3"-actin. These 
filaments may be dysfunctional like those present in the/3,m 
transfectants because similar changes in the expression and 
cellular organization of Tm 2 are observed. In contrast, no 
changes in the cellular organization and expression of Tm 5 
were observed in these actin transfectants. It appears that Tm 
5 preferentially segregates into filaments in all these cells 
suggesting that Tm 5 does not discriminate between different 
actin templates. 
We propose two possible mechanisms by which the ob- 
served relationship between cytoarchitectural changes and 
cytoskeletal gene expression may take place. First, it is pos- 
sible that different populations of actin filaments exist in the 
cell and some of these filaments have a better association 
with Tm 5 than others. In the/3~ and 3'-actin transfectants 
the Tm 5-associated filaments may not have been altered, 
with no consequent alterations in Tm 5 organization. Rather, 
a second class of filaments containing mainly the Tm 2 iso- 
form would be predicted to be largely eliminated in the 
3'- and B,~-actin transfectants. Such a  mechanism may be 
unlikely to occur considering the findings of Lin and co- 
worker (1986). They report that immunoprecipitation of tro- 
pomyosin-containing actin filaments with isoform-specific 
tropomyosin antibodies precipitates all filaments. This sug- 
gests that different populations of actin filaments associated 
with specific tropomyosin isoforms are unlikely to be pres- 
ent. A second possible molecular mechanism that may ac- 
count for the observed differential organization and expres- 
sion of tropomyosin isoforms has been proposed to operate 
during myogenesis (Gunning et ai., 1990).  The model sug- 
gests that competition exists between isoforms of  a particular 
cytoskeletal component for inclusion into cellular structures 
and that the level of gene expression is determined by the 
competitiveness of  the individual isoforms. The observations 
presented in this study would support this model. In the case 
of the 3'- and fl~-actin transfectants, failure of Tm 2 to seg- 
regate into stress fibers is proposed to lead to the downregu- 
lation of this isoform. In contrast, the ability of Tin 5 to con- 
tinue to segregate into stress fibers results in no change in 
the levels of  Tm 5. These results are therefore consistent with 
a feedback regulatory mechanism where cellular demand for 
a particular structural protein can regulate the mRNA levels. 
For example, the findings by Weinberger et al. (1992) reveal 
that the induction and maintenance of the neuronal tropo- 
myosins is dependent on morphological differentiation and 
the maintenance of the neuronal phenotype. Similar feed- 
back regulatory mechanism have also been previously dem- 
onstrated for tubulin (Cleveland,  1989) and more recently 
for actin (Lloyd et ai,,  1992). 
Similar models have been previously proposed  for the 
global autoregulation of the cytoskeleton by Ben-Ze'ev (for 
review see Ben-Ze'ev,  1991). In these experiments cell shape 
changes induced by inhibiting cell-matrix and cell-cell con- 
tacts, stimulation with growth factors, cell differentiation, 
and transformation by either chemical carcinogens or tumor 
viruses were found to correlate with changes in the expres- 
sion of  a number of  cytoskeletal components. Although such 
a correlation has been previously documented, the difference 
between those experiments and the ones presented in this 
manuscript is the manner in which the cytoskeletal altera- 
tions are induced. This is important in determining whether 
a  direct causal relationship exists between changes in cell 
shape and the expression of cytoskeletal components or are 
the observed changes in gene expression initially induced by 
a different pathway that is independent of the cell cytoskele- 
ton. Because of the complex manner in which information 
from the outside environment can be transmitted to the cell 
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sion induced by the above methods can initially by-pass the 
cell cytoskeleton. A mechanism to explain how this may oc- 
cur could involve a second messenger system and/or regula- 
tory molecules that could directly influence gene expression 
independent of the cytoskeleton. In contrast, the manner in 
which we have induced cytoskeletal changes in the ¢22 cells 
was  by  directly  influencing  the  expression  of  a  major 
cytoskeletal  component. We therefore postulate that the ob- 
served changes in morphology and/or cytoskeletal gene ex- 
pression are a direct result of altering aetin gene expression. 
In  summary,  this apparent direct  link between  actin  and 
tropomyosin  expression presented  in this manuscript  sug- 
gests  that  nonpharrnacological  signals  originating  in  the 
cytoskeleton can regulate cytoarchitectural gene expression. 
Different Tropomyosin Isoforms May Discriminate 
between/3- and 7-act/n 
Our initial aim has been to understand the functional  sig- 
nificance of different cytoskeletal isoforms. In our previous 
study we showed that elevated  expression of/3- or 7-actin 
genes resulted in a reciprocal impact on myoblast shape and 
actin filament organization  (Schevzov et al.,  1992).  In the 
present study we show that these actin transfectants display 
a  differential  organization  and  expression of tropomyosin 
isoforms.  Hence,  a possible mechanism by which/3-  and 
T-actin may elicit the observed reciprocal  changes in myo- 
blast cytoarchitecture  is by differential regulation of tropo- 
myosin isoforms.  In particular, ~actin may provide a better 
template for association with the high M, tropomyosins than 
~,-actin. This would in turn promote stress fiber stability in 
/3-actin transfectants and undermine  stability  in the ~,-actin 
transfectants. Stress fiber stability would be seen as a major 
determinant of cell morphology which is consistent with the 
work of Liu and Bretscher  (1989)  in yeast. 
The work of Leavitt et al. (Ng et al., 1988) further empha- 
sizes the correlation between the decrease in the/3:-y ratio 
and downregulation  in the synthesis  of the high M, tropo- 
myosin isoforms. In these experiments a decrease in the/3:'y 
ratio induced by overexpression  of the 7-actin gene in HuT- 
14T cells resulted in a 36-65 % decrease in the protein syn- 
thesis of Tin 3 and to a lesser extent Tm I and 6. In contrast, 
increasing the/3:7 ratio had no impact on tropomyosin syn- 
thesis (Ng et al.,  1988). Thus, it may be suggested that in 
both myoblasts and transformed fibroblasts, the/3:~ ratio can 
influence  tropomyosin  synthesis. 
The differential expression of tropomyosin isoforms im- 
plies that they are independently  regulated and thus may be 
functionally  distinct. These studies are supported in part by 
the work of Matsumura and Yamashiro-Matsumura (1985) 
where in vitro studies  have shown differential  affinities  of 
tropomyosin  isoforms for the actin  filaments.  In addition, 
immunofluorescence studies  on normal cultured  fibroblast 
ceils suggest a differential localization of tropomyosin iso- 
forms (Lin et al.,  1988). Moreover, the morphological and 
cytoarchitectural  changes observed after the transformation 
of cells have also been correlated with a differential pattern 
of expression of tropomyosin isoforms (Cooper et al., 1985; 
Hendricks and Weintraub, 1984; Leavitt et al., 1986; Lin et 
al., 1985b; Matsumura et al., 1983). These observations are 
consistent with the proposal that the tropomyosin isoform 
composition of microfilaments may play a fundamental role 
in regulating cell cytoarchitecture. 
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